AMG-458
AMG-458[edit | edit source]
AMG-458 is a small molecule inhibitor that targets the c-Met receptor tyrosine kinase, which is implicated in various forms of cancer. The c-Met receptor, also known as hepatocyte growth factor receptor (HGFR), plays a crucial role in cellular processes such as proliferation, survival, and metastasis. Dysregulation of c-Met signaling is associated with tumorigenesis and cancer progression, making it a significant target for cancer therapy.
Mechanism of Action[edit | edit source]
AMG-458 functions by selectively inhibiting the c-Met receptor tyrosine kinase. By binding to the ATP-binding site of the c-Met receptor, AMG-458 prevents the phosphorylation of the receptor and subsequent activation of downstream signaling pathways. This inhibition disrupts processes such as cell growth, angiogenesis, and metastasis, which are essential for cancer development and progression.
Clinical Development[edit | edit source]
AMG-458 has been evaluated in preclinical studies and early-phase clinical trials to assess its efficacy and safety profile. These studies have demonstrated that AMG-458 can effectively inhibit c-Met activity and reduce tumor growth in various cancer models. However, further clinical trials are necessary to fully establish its therapeutic potential and determine the optimal dosing regimen.
Potential Applications[edit | edit source]
The primary application of AMG-458 is in the treatment of cancers that exhibit aberrant c-Met signaling. This includes certain types of lung cancer, gastric cancer, and renal cell carcinoma, among others. By targeting the c-Met pathway, AMG-458 offers a promising therapeutic strategy for patients with tumors that are resistant to conventional therapies.
Side Effects and Safety[edit | edit source]
As with many targeted therapies, the use of AMG-458 may be associated with specific side effects. Common adverse effects observed in clinical trials include fatigue, nausea, and elevated liver enzymes. Ongoing studies aim to better understand the safety profile of AMG-458 and manage any potential toxicities.
Also see[edit | edit source]
Template:Receptor tyrosine kinase inhibitors
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
